These drugs were hailed by proponents as breakthroughs in the fight to treat Alzheimer’s disease, but a new independent ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...

Top drugmakers have spent more than a decade investigating and advancing anti-amyloid Alzheimer's medicines in clinical ...

Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't ...

Reproductive symptoms, temperature-related complaints, and psychiatric symptoms are among the side effects of GLP-1s reported ...

Some users of popular weight-loss drugs such as Ozempic are reporting a possible side effect being referred to online as ...

A medical oncologist called the late-stage clinical trial results "remarkable," though Sasse said the drug means his body ...

One of the most fascinating aspects of this discovery is the role of artificial intelligence. Researchers developed a tool ...

Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing ...

A single batch of the widely prescribed anti-anxiety drug Xanax has been recalled, according to the Food and Drug ...

Rezdiffra (resmetirom) is a brand-name drug prescribed for a type of liver disease called metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH) ...